Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Joint Bone Spine ; 73(4): 456-8, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16087379

RESUMO

Amyloid arthropathy occurs chiefly as a manifestation of beta(2) microglobulin amyloidosis in patients receiving chronic hemodialysis. AL amyloidosis complicating multiple myeloma is a less common cause. Amyloid arthropathy is exceedingly rare in patients with Waldenström macroglobulinemia. We report a case characterized by lymphoplasmocytoid malignancy with monoclonal IgM production and amyloid arthropathy manifesting as bilateral symmetric polyarthritis. A synovial membrane biopsy established the diagnosis. Chemotherapy was effective in alleviating the joint manifestations. Joint symptoms in patients with monoclonal gammopathies, including those characterized by IgM secretion, should suggest amyloid arthropathy. Treatment of the blood disease may improve the joint symptoms.


Assuntos
Amiloidose/complicações , Artropatias/complicações , Macroglobulinemia de Waldenstrom/complicações , Idoso , Amiloidose/patologia , Artroscopia , Biópsia , Diagnóstico Diferencial , Progressão da Doença , Humanos , Artropatias/patologia , Masculino
2.
J Neurosci Methods ; 140(1-2): 23-8, 2004 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-15589330

RESUMO

This report describes technical adaptations of a traumatic brain injury (TBI) model-largely inspired by Marmarou-in order to monitor microdialysis data and PtiO2 (brain tissue oxygen) before, during and after injury. We particularly focalize on our model requirements which allows us to re-create some drastic pathological characteristics experienced by severely head-injured patients: impact on a closed skull, no ventilation immediately after impact, presence of diffuse axonal injuries and secondary brain insults from systemic origin... We notably give priority to minimize anaesthesia duration in order to tend to banish any neuroprotection. Our new model will henceforth allow a better understanding of neurochemical and biochemical alterations resulting from traumatic brain injury, using microdialysis and PtiO2 techniques already monitored in our Intensive Care Unit. Studies on efficiency and therapeutic window of neuroprotective pharmacological molecules are now conceivable to ameliorate severe head-injury treatment.


Assuntos
Aceleração/efeitos adversos , Lesões Encefálicas/fisiopatologia , Lesão Axonal Difusa/fisiopatologia , Traumatismos Cranianos Fechados/fisiopatologia , Anestésicos Gerais/farmacologia , Animais , Encéfalo/patologia , Encéfalo/fisiopatologia , Lesões Encefálicas/tratamento farmacológico , Lesões Encefálicas/patologia , Lesão Axonal Difusa/patologia , Modelos Animais de Doenças , Líquido Extracelular/metabolismo , Traumatismos Cranianos Fechados/patologia , Masculino , Microdiálise , Degeneração Neural/patologia , Degeneração Neural/fisiopatologia , Fármacos Neuroprotetores/farmacologia , Consumo de Oxigênio/fisiologia , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...